Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Lin

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Scientific Data|June 24, 2022
A multi-city urban atmospheric greenhouse gas measurement data synthesisLogan E Mitchell, John C Lin, Lucy R Hutyra, et al.
Nature Biotechnology|September 29, 2015
A catalog of the mouse gut metagenomeLiang Xiao, Qiang Feng, Suisha Liang, et al.
Nature Biotechnology|January 4, 2019
Amendments: Author Correction: A catalog of the mouse gut metagenomeLiang Xiao, Qiang Feng, Suisha Liang, et al.
Scientific Reports|July 14, 2021
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuningLauric Haber, Kara Olson, Marcus P Kelly, et al.
Science Translational Medicine|March 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivoRobert Salzler, David J DiLillo, Kei Saotome, et al.
Critical Care Medicine|February 22, 2019
Short-Term Adverse Outcomes Associated With Hypoglycemia in Critically Ill ChildrenEdward Vincent S Faustino, Eliotte L Hirshberg, Lisa A Asaro, et al.
JAMA Pediatrics|May 2, 2022
Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR CollaborativeCharlotte Z Woods-Hill, Elizabeth A Colantuoni, Danielle W Koontz, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Scientific Data|June 24, 2022
A multi-city urban atmospheric greenhouse gas measurement data synthesisLogan E Mitchell, John C Lin, Lucy R Hutyra, et al.
Nature Biotechnology|September 29, 2015
A catalog of the mouse gut metagenomeLiang Xiao, Qiang Feng, Suisha Liang, et al.
Nature Biotechnology|January 4, 2019
Amendments: Author Correction: A catalog of the mouse gut metagenomeLiang Xiao, Qiang Feng, Suisha Liang, et al.
Scientific Reports|July 14, 2021
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuningLauric Haber, Kara Olson, Marcus P Kelly, et al.
Science Translational Medicine|March 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivoRobert Salzler, David J DiLillo, Kei Saotome, et al.
Critical Care Medicine|February 22, 2019
Short-Term Adverse Outcomes Associated With Hypoglycemia in Critically Ill ChildrenEdward Vincent S Faustino, Eliotte L Hirshberg, Lisa A Asaro, et al.
JAMA Pediatrics|May 2, 2022
Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR CollaborativeCharlotte Z Woods-Hill, Elizabeth A Colantuoni, Danielle W Koontz, et al.
Science Translational Medicine|June 26, 2020
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapyJanelle C Waite, Bei Wang, Lauric Haber, et al.
Nature Medicine|January 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockadeEdgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo, et al.
Pageof 17